The FINANCIAL — Astellas Pharma Inc. on February 24 announced that it submitted a new drug application for a guanylate cyclase-C (GC-C) receptor agonist, linaclotide (generic name, ASP0456) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results